Related Experiment Videos
From overload to failure: what happens inside the myocyte
S E Harding1, K Davia, C H Davies
1National Heart and Lung Institute, Imperial College School of Medicine, London, UK. sian.harding@ic.ac.uk
Annals of Medicine
|November 4, 1998
Summary
Studies on human heart muscle cells (myocytes) from failing hearts reveal slower contractions and relaxation, independent of cell size. These cellular defects suggest targeted therapies for heart failure.
Area of Science:
- Cardiology
- Cellular Biology
- Physiology
Background:
- Human heart failure involves complex cellular and molecular changes.
- Understanding individual cardiac myocyte function is crucial for identifying therapeutic targets.
Purpose of the Study:
- To investigate functional defects in surviving cardiac myocytes from failing human hearts.
- To correlate myocyte dysfunction with heart disease severity and hypertrophy.
Main Methods:
- Isolation of individual myocytes from normal and failing human myocardium.
- Assessment of myocyte contractility, relaxation, and action potential properties.
- Evaluation of beta-adrenoceptor function and K+ current density.
Main Results:
- Failing myocytes exhibit significantly slower contraction and relaxation.
- Reduced contraction amplitude observed at physiological stimulation frequencies.
- Action potentials are prolonged, linked to altered K+ current density.
- Beta-adrenoceptor desensitization correlates with disease severity and patient age.
Conclusions:
- Functional deficits in failing human cardiac myocytes are evident at the cellular level.
- These cellular defects are independent of myocyte size but linked to hypertrophy.
- Targeting surviving myocytes offers a promising therapeutic strategy for heart failure.